VANCOUVER, Canada — Optical coherence tomography (OCT) angiography can help predict which eyes affected by age-related macular degeneration are most likely to develop exudation, research shows. The ...

"It is not necessary to measure the extent, height, or length of the DLS [double layer sign]. It is sufficient to know, however, that when DLS is seen that it’s a key risk factor and that regular ...

Pegcetacoplan injections slowed progression of geographic atrophy but had no impact on visual acuity in a real-world setting, ...

There are no effective treatments to stop the disease, but new research points to underlying causes Drugs that target a key biochemical pathway might lead to better therapies WEDNESDAY, Oct. 2, 2024 ...

A five-year image-based study in people with type 2 diabetes found metformin use was associated with lower odds of developing ...

Conditions that resemble age-related macular degeneration (AMD) can differ considerably from AMD regarding prognosis, inheritance, monitoring and therapy. Differential diagnoses of AMD include other ...

While pivotal research on therapies for neovascular age-related macular degeneration (nAMD) and geographic atrophy (GA) focused on one condition or the other, retina specialists commonly encounter ...

PHILADELPHIA, Pennsylvania — Researchers saw a decrease in macular volume during the first year of fingolimod (Gilenya, Novartis) treatment among patients with multiple sclerosis (MS), according to a ...

syfovre, also known as pegcetacoplan, is a medicine used to treat geographic atrophy, which is the advanced form of dry age-related macular degeneration. Geographic atrophy can cause irreversible ...